Christopher M. Marks has cultivated a distinguished career in corporate finance and investment management, where he excels as a strategic advisor to growth-focused enterprises. With significant expertise in guiding companies through pivotal development phases, his leadership impacts various sectors ranging from technology to healthcare. He has been instrumental in fostering innovation while maximizing operational efficiencies for firms at critical inflection points. His extensive background includes influential roles within both public and private markets, positioning him as a valuable asset in enhancing corporate value and navigating complex market landscapes.
Christopher M. Marks has cultivated a distinguished career in corporate finance and investment management, where he excels as a strategic advisor to growth-focused enterprises. With significant expertise in guiding companies through pivotal development phases, his leadership impacts various sectors ranging from technology to healthcare. He has been instrumental in fostering innovation while maximizing operational efficiencies for firms at critical inflection points. His extensive background includes influential roles within both public and private markets, positioning him as a valuable asset in enhancing corporate value and navigating complex market landscapes.
Focused on identifying transformative opportunities, Christopher M. Marks leverages his profound expertise in corporate finance to optimize the strategic positioning of growth-oriented ventures. His approach emphasizes innovation as a core driver for enhancing enterprise value across diverse industries, including technology and healthcare. By fostering strong operational efficiencies and guiding firms through critical developmental stages, he ensures they capitalize effectively on market dynamics. This unique blend of skills allows for dynamic decision-making that aligns closely with the evolving needs of each organization.
Focused on identifying transformative opportunities, Christopher M. Marks leverages his profound expertise in corporate finance to optimize the strategic positioning of growth-oriented ventures. His approach emphasizes innovation as a core driver for enhancing enterprise value across diverse industries, including technology and healthcare. By fostering strong operational efficiencies and guiding firms through critical developmental stages, he ensures they capitalize effectively on market dynamics. This unique blend of skills allows for dynamic decision-making that aligns closely with the evolving needs of each organization.
| Trades 2324 | Longs Won 1526/2324 65% | Profit Factor 5.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $340,591.75 |
| Average Win $104,584.28 | Best Trade (Jun 30) $6M | Sharpe Ratio -9.24 |
| Average Loss -$36,798.84 | Worst Trade (Sep 30) -$4.36M | Z-Score -5.54 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 3w 2d | Expectancy $56,037.04 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 10,989 | 9,890 | 8,791 | 7,692 | 6,593 | 5,495 | 4,396 | 3,297 | 2,198 | 1,099 |